RCKT Rocket Pharmaceuticals Inc

USD 17.45 0.00 ( 0.00)%
Icon

Rocket Pharmaceuticals Inc (RCKT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 17.45

0.00 (0.00)%

USD 1.60B

0.90M

USD 52.33(+199.90%)

USD 28.25 (+61.89%)

Icon

RCKT

Rocket Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 17.45
0.00 ( 0.00)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.60B

USD 28.25 (+61.89%)

USD 17.45

Rocket Pharmaceuticals Inc (RCKT) Stock Forecast

Show ratings and price targets of :
USD 52.33
(+199.90%)

Based on the Rocket Pharmaceuticals Inc stock forecast from 7 analysts, the average analyst target price for Rocket Pharmaceuticals Inc is USD 52.33 over the next 12 months. Rocket Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Rocket Pharmaceuticals Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Rocket Pharmaceuticals Inc’s stock price was USD 17.45. Rocket Pharmaceuticals Inc’s stock price has changed by +2.77% over the past week, +5.44% over the past month and -5.93% over the last year.

No recent analyst target price found for Rocket Pharmaceuticals Inc
No recent average analyst rating found for Rocket Pharmaceuticals Inc

Company Overview Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic d...Read More

9 Cedarbrook Drive, Cranbury, NJ, United States, 08512

268

December

USD

USA

Adjusted Closing Price for Rocket Pharmaceuticals Inc (RCKT)

Loading...

Unadjusted Closing Price for Rocket Pharmaceuticals Inc (RCKT)

Loading...

Share Trading Volume for Rocket Pharmaceuticals Inc Shares

Loading...

Compare Performance of Rocket Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for RCKT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Rocket Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD121.60B 32.57 250.99

Frequently Asked Questions About Rocket Pharmaceuticals Inc (RCKT) Stock

Based on ratings from 7 analysts Rocket Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 12 buy, sell and hold ratings.

Unfortunately we do not have enough data on RCKT's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for RCKT is USD 52.33 over the next 12 months. The maximum analyst target price is USD 65 while the minimum anlayst target price is USD 38.

Unfortunately we do not have enough data on RCKT's stock to indicate if its overvalued.

The last closing price of RCKT's stock was USD 17.45.

The most recent market capitalization for RCKT is USD 1.60B.

Based on targets from 7 analysts, the average taret price for RCKT is projected at USD 52.33 over the next 12 months. This means that RCKT's stock price may go up by +199.90% over the next 12 months.

We can't find any ETFs which contains Rocket Pharmaceuticals Inc's stock.

As per our most recent records Rocket Pharmaceuticals Inc has 268 Employees.

Rocket Pharmaceuticals Inc's registered address is 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512. You can get more information about it from Rocket Pharmaceuticals Inc's website at https://www.rocketpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Rocket Pharmaceuticals Inc (RCKT) Stock

Based on ratings from 7 analysts Rocket Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 12 buy, sell and hold ratings.

Unfortunately we do not have enough data on RCKT's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for RCKT is USD 52.33 over the next 12 months. The maximum analyst target price is USD 65 while the minimum anlayst target price is USD 38.

Unfortunately we do not have enough data on RCKT's stock to indicate if its overvalued.

The last closing price of RCKT's stock was USD 17.45.

The most recent market capitalization for RCKT is USD 1.60B.

Based on targets from 7 analysts, the average taret price for RCKT is projected at USD 52.33 over the next 12 months. This means that RCKT's stock price may go up by +199.90% over the next 12 months.

We can't find any ETFs which contains Rocket Pharmaceuticals Inc's stock.

As per our most recent records Rocket Pharmaceuticals Inc has 268 Employees.

Rocket Pharmaceuticals Inc's registered address is 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512. You can get more information about it from Rocket Pharmaceuticals Inc's website at https://www.rocketpharma.com.
Loading...